FOR IMMEDIATE RELEASE

Succesful Completion of ISO Audit

Ogden, UT, December 16, 2005 - Computerized Thermal Imaging, Inc a designer and manufacturer of medical diagnostic equipment utilizing infrared and thermal technologies announced today that they have successfully completed a follow-up audit of their quality management system by VDE/DQS of Germany. The results of the audit included maintenance of certification to ISO 13485:1996 (Standards for Medical Devices), CMDCAS (Canadian Medical Devices Conformity Assessment System) and certification to ANNEX II of the Medical Device Directive (93/42/EEC).

Richard Secord, CEO, commented that "this certification to the European and Canadian standards represents a commitment that CTI has to continual improvement and the application of thermal technology in providing healthcare solutions and services worldwide." CTI is continuing to improve their Quality Management System and is now preparing to certify to the latest European and Canadian standards, ISO/CMDCAS 13485:2003. It is expected that this certification will be achieved in the first quarter of 2006.

This Current Report on Form 8-K contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Among those risks, trends and uncertainties are CTI's pending application before the FDA seeking pre-market approval of CTI's BCS 2100 breast imaging system, CTI's ability to raise additional capital to fund cash requirements for future operations and CTI's ability to continue as a going concern. In particular, careful consideration should be given to cautionary statements made in the various reports CTI has filed with the Securities and Exchange Commission. CTI undertakes no duty to update or revise these forward-looking statements.

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are subject to certain risks, trends and certainties that could cause actual results to differ materially from those projected. Among those risks, trends and uncertainties are CTI's ability to continue as a going concern given its current financial condition, CTI's pending application before the FDA seeking pre-market approval of CTI's BCS 2100 breast imaging system, and CTI's ability to raise additional capital to fund cash requirements for future operations. In particular, careful consideration should be given to cautionary statements made in the various reports CTI has filed with the Securities and Exchange Commission. CTI undertakes no duty to update or revise such forward-looking statements.